“Comparative Efficacy of Tirzepatide, Teneligliptin, and Empagliflozin in HbA1c Reduction in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis” (2023) International Journal of Medical and Surgical Sciences, 10(3), pp. 1–18. doi:10.32457/ijmss.v10i3.2263.